Tungsten (VI) salts used to treat infertility, for stimulating fertility and normal reproduction in a non-diabetic female mammal, and for improving the effectiveness of assisted reproduction techniques
AssigneeOxolike, S.L.
InventorsIgnacio Canals Almazán, Agnès Arbat Bugié
Life of this patent
Estimating the term…
Abstract
The invention relates to tungsten (VI) salts for use thereof in the treatment of infertility in a non-diabetic female mammal, for favoring normal reproduction and fertility in a non-diabetic female mammal, or for increasing the efficacy of an assisted reproductive technique applied to a mammal, as well as compositions containing same and methods for treatment using same.
Claims18
A method for favoring normal reproduction and fertility or for increasing efficacy of an assisted reproductive technique in a non-diabetic female mammal, said method comprising administering to said mammal tungsten (VI) salt, or a solvate thereof;
- wherein said salt is administered at a daily dose of between 0.001 mg and 1000 mg of the tungsten (VI) salt per kg of body weight of the mammal;
- wherein said mammal is not infertile,
- wherein the normal reproduction and fertility is a state of fertility in which pregnancy is achieved in a period of 12 months of regular, unprotected sexual intercourse;
- and
- wherein the assisted reproductive technique is selected from a technique comprising induction of ovulation, artificial insemination or in vitro fertilization;
- such that the normal reproduction and fertility in said mammal is favored or the efficacy of said assisted reproductive technique in said mammal is increased.
A method for favoring normal reproduction and fertility or for increasing efficacy of an assisted reproductive technique in a non-diabetic female mammal, said method comprising administering to said mammal a composition comprising a tungsten (VI) salt or a solvate thereof and at least one pharmaceutically, veterinary or dietetically acceptable excipient or vehicle, wherein said mammal is not infertile, such that the normal reproduction and fertility in said mammal is favored or the efficacy of said assisted reproductive technique in said mammal is increased, wherein the tungsten (VI) salt or a solvate thereof is present in said composition at a concentration equal to or greater than 100 mg of the tungsten (VI) salt or a solvate thereof per kg of the composition;
- wherein the normal reproduction and fertility is a state of fertility in which pregnancy is achieved in a period of 12 months of regular, unprotected sexual intercourse;
- and
- wherein the assisted reproductive technique is selected from a technique comprising induction of ovulation, artificial insemination or in vitro fertilization.
Dependencies are inferred from the claim text.